|4Feb 18, 4:20 PM ET

Attar Eyal C. 4

4 · Vor Biopharma Inc. · Filed Feb 18, 2025

Insider Transaction Report

Form 4
Period: 2025-02-13
Attar Eyal C.
CHIEF MEDICAL OFFICER
Transactions
  • Sale

    Common Stock

    2025-02-13$1.42/sh2,227$3,162126,625 total
Footnotes (1)
  • [F1]The transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024.

Documents

1 file
  • 4
    form4-02182025_090225.xmlPrimary